Do "Reverse Payment" Settlements of Brand-Generic Patent Disputes in the Pharmaceutical Industry Constitute an Anticompetitive Pay for Delay? / Drake, Keith M.

Author/creator Drake, Keith M.
Format Electronic
Publication Info[S.l.] : National Bureau of Economic Research,
Supplemental ContentFull text available from NBER Working Papers

General noteTitle from content provider.
Access restrictionAvailable only to authorized users.
Technical detailsMode of access: World Wide Web
Genre/formElectronic books.